LeMaitre Vascular Net Profit Margin 2010-2025 | LMAT
LeMaitre Vascular net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| LeMaitre Vascular Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-03-31 | $0.23B | $0.05B | 19.82% |
| 2024-12-31 | $0.22B | $0.04B | 20.00% |
| 2024-09-30 | $0.21B | $0.04B | 19.25% |
| 2024-06-30 | $0.21B | $0.04B | 18.54% |
| 2024-03-31 | $0.20B | $0.03B | 17.09% |
| 2023-12-31 | $0.19B | $0.03B | 15.54% |
| 2023-09-30 | $0.19B | $0.03B | 15.14% |
| 2023-06-30 | $0.18B | $0.03B | 14.12% |
| 2023-03-31 | $0.17B | $0.02B | 12.43% |
| 2022-12-31 | $0.16B | $0.02B | 12.96% |
| 2022-09-30 | $0.16B | $0.02B | 13.04% |
| 2022-06-30 | $0.16B | $0.02B | 14.38% |
| 2022-03-31 | $0.16B | $0.03B | 16.98% |
| 2021-12-31 | $0.16B | $0.03B | 17.42% |
| 2021-09-30 | $0.15B | $0.03B | 18.30% |
| 2021-06-30 | $0.15B | $0.03B | 19.21% |
| 2021-03-31 | $0.14B | $0.03B | 18.52% |
| 2020-12-31 | $0.13B | $0.02B | 16.92% |
| 2020-09-30 | $0.12B | $0.02B | 16.39% |
| 2020-06-30 | $0.12B | $0.02B | 14.78% |
| 2020-03-31 | $0.12B | $0.02B | 15.13% |
| 2019-12-31 | $0.12B | $0.02B | 16.38% |
| 2019-09-30 | $0.11B | $0.02B | 17.54% |
| 2019-06-30 | $0.11B | $0.02B | 17.43% |
| 2019-03-31 | $0.11B | $0.02B | 21.50% |
| 2018-12-31 | $0.11B | $0.02B | 21.90% |
| 2018-09-30 | $0.10B | $0.02B | 20.39% |
| 2018-06-30 | $0.10B | $0.02B | 21.15% |
| 2018-03-31 | $0.10B | $0.02B | 17.48% |
| 2017-12-31 | $0.10B | $0.02B | 16.83% |
| 2017-09-30 | $0.10B | $0.02B | 16.33% |
| 2017-06-30 | $0.10B | $0.01B | 14.58% |
| 2017-03-31 | $0.09B | $0.01B | 13.04% |
| 2016-12-31 | $0.09B | $0.01B | 12.50% |
| 2016-09-30 | $0.09B | $0.01B | 12.94% |
| 2016-06-30 | $0.08B | $0.01B | 12.35% |
| 2016-03-31 | $0.08B | $0.01B | 11.39% |
| 2015-12-31 | $0.08B | $0.01B | 10.26% |
| 2015-09-30 | $0.08B | $0.01B | 9.09% |
| 2015-06-30 | $0.08B | $0.01B | 7.89% |
| 2015-03-31 | $0.07B | $0.01B | 6.76% |
| 2014-12-31 | $0.07B | $0.00B | 5.56% |
| 2014-09-30 | $0.07B | $0.00B | 4.23% |
| 2014-06-30 | $0.07B | $0.00B | 4.41% |
| 2014-03-31 | $0.07B | $0.00B | 4.55% |
| 2013-12-31 | $0.06B | $0.00B | 6.25% |
| 2013-09-30 | $0.06B | $0.00B | 6.56% |
| 2013-06-30 | $0.06B | $0.00B | 6.67% |
| 2013-03-31 | $0.06B | $0.00B | 6.90% |
| 2012-12-31 | $0.06B | $0.00B | 5.26% |
| 2012-09-30 | $0.06B | $0.00B | 3.64% |
| 2012-06-30 | $0.06B | $0.00B | 3.57% |
| 2012-03-31 | $0.06B | $0.00B | 3.51% |
| 2011-12-31 | $0.06B | $0.00B | 3.45% |
| 2011-09-30 | $0.06B | $0.00B | 6.78% |
| 2011-06-30 | $0.06B | $0.01B | 8.62% |
| 2011-03-31 | $0.06B | $0.01B | 10.53% |
| 2010-12-31 | $0.06B | $0.01B | 12.50% |
| 2010-09-30 | $0.06B | $0.01B | 10.71% |
| 2010-06-30 | $0.06B | $0.01B | 9.09% |
| 2010-03-31 | $0.05B | $0.00B | 7.41% |
| 2009-12-31 | $0.05B | $0.00B | 1.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.901B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $151.037B | 37.81 |
| Stryker (SYK) | United States | $146.527B | 30.64 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $112.146B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.313B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.844B | 28.38 |
| ResMed (RMD) | United States | $36.979B | 27.78 |
| Agilent Technologies (A) | United States | $32.895B | 21.44 |
| GE HealthCare Technologies (GEHC) | United States | $32.794B | 15.57 |
| Terumo (TRUMY) | Japan | $26.561B | 34.50 |
| Koninklijke Philips (PHG) | Netherlands | $22.051B | 15.85 |
| Insulet (PODD) | United States | $21.941B | 86.12 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.277B | 11.74 |
| Baxter (BAX) | United States | $15.529B | 11.59 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.253B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.430B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.971B | 20.78 |
| Lantheus Holdings (LNTH) | United States | $5.642B | 14.23 |
| Prestige Consumer Healthcare (PBH) | United States | $4.203B | 18.78 |
| Perrigo (PRGO) | Ireland | $3.596B | 9.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.385B | 15.42 |
| ICU Medical (ICUI) | United States | $3.275B | 24.15 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $1.997B | 13.73 |
| AtriCure (ATRC) | United States | $1.730B | 0.00 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.201B | 12.19 |
| Neogen (NEOG) | United States | $1.131B | 14.47 |
| BioLife Solutions (BLFS) | United States | $1.126B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.100B | 24.74 |
| Kestra Medical Technologies (KMTS) | United States | $1.063B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
| InMode (INMD) | Israel | $0.895B | 9.02 |
| Capricor Therapeutics (CAPR) | United States | $0.650B | 0.00 |
| Evolus (EOLS) | United States | $0.647B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Owens & Minor (OMI) | United States | $0.619B | 5.13 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.584B | 0.00 |
| Valneva SE (VALN) | France | $0.515B | 0.00 |
| Surmodics (SRDX) | United States | $0.420B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.408B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.76 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.322B | 57.20 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.87 |
| Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.216B | 0.00 |
| Biote (BTMD) | United States | $0.210B | 5.89 |
| Quanterix (QTRX) | United States | $0.209B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 52.25 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.86 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 16.54 |
| Jin Medical (ZJYL) | China | $0.120B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.59 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.14 |
| Nephros (NEPH) | United States | $0.036B | 48.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |